SCHEMBL30336281

SCHEMBL30336281

Cc1nc(N2CCC(C(F)(F)F)CC2)ccc1Nc1ccc2c(c1)n(C)c(=O)n2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL6 P41182 6/20 0.47
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
TP53 P04637 2/20 0.36
TRPV3 Q8NET8 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NCOR2 Q9Y618 1/20 0.34
TRIM24 O15164 1/20 0.34
TRPA1 O75762 1/20 0.34
PKM P14618 2/20 0.34
BRD1 O95696 1/20 0.34
BRPF1 P55201 1/20 0.34
JAK1 P23458 1/20 0.34
JAK3 P52333 1/20 0.34
CCNT1 O60563 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865789 1.00 BCL6 (0.47) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL24865698 0.88 BCL6 (0.45) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL24865777 0.83 BCL6 (0.48) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL31123303 0.83 BCL6 (0.48) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL24865775 0.83 MAPT (0.51) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL31123194 0.83 MAPT (0.51) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL24865781 0.80 BCL6 (0.47) BCL6SMN1; SMN2GAAKDM4EMAPT
SCHEMBL31123270 0.79 BCL6 (0.50) BCL6SMN1; SMN2GAATP53ALDH1A1
SCHEMBL24865299 0.79 BCL6 (0.50) BCL6SMN1; SMN2GAATP53ALDH1A1
SCHEMBL24865774 0.78 BCL6 (0.45) BCL6SMN1; SMN2GAATP53TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 BCL6 390/4885SMN1; SMN2 1657/4885GAA 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.